Drawing for HIPRA

USPTO serial 75475453

HIPRA

Reviewed by CopyMark Law Group

Reg. 2361218Status 800Registered
Filing date
Status date
Registration date
Jun 27, 2000
Examiner
FRENCH, CURTIS W
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with HIPRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

HORST M KASPER

HORST M KASPER KASPER & LAUGHLIN13 Forest DriveWARREN, NJ 07059UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005VETERINARY VACCINES FOR BIRDS, RABBIT, LAMB, SHEEP, PIG, SWINE, CALVE, COW AND EWE, DOG, CAT; LIVE VACCINES AND INACTIVATED VACCINES FOR POULTRY, FOR THE TREATMENT OF EDS- EGG DROP SYNDROME 76, GUMBORO DISEASE, NEWCASTLE DISEASE, IB - INFECTIOUS BRONCHITIS MYCOPLASMOSIS, PASTEURELLOSIS, RHINOTRACHEITIS, SALMONELLOSIS, SHS SWOLLEN HEAD SYNDROME, INFECTIOUS CORYZA, ILT - INFECTIOUS LARYNGOTRACHEITIS; ORAL ANTIBIOTICS AND CHEMOTHERAPIC SULPHONAMIDES FOR POULTRY, FOR THE TREATMENT OF VITAMIN DEFICIENCIES, CONVALESCENCES, GROWTH STIMULANT, STRESS, MALABSORPTION SYNDROME; BIOLOGICAL PREPARATIONS FOR RABBITS FOR THE TREATMENT OF RHD - RABBIT HAEMORRHAGIC DISEASE; ENTEROTOXAEMIA, GENITAL INFECTIONS, PNEUMONIA, OTITIS, PASTEURELLOSIS, RHINITIS, SEPTICEMIA, MYXOMATOSIS; ORAL VITAMINS FOR RABBITS FOR THE TREATMENT OF ABORTION AND VITAMIN DEFICIENCIES; ORAL ANTIBIOTICS AND CHEMOTHERAPIC SULPHANOMIDES FOR RABBITS FOT THE TREATMENT OF CUTANEOUS ABSCESSES, FOOT INFECTIONS AGALAXIA, COCCIDIOSSI, NON-SPECIFIC DIARRHOEA, TYZZER'S DISEASE, RHD - RABBIT HAEMORRHAGIC DISEASE; BIOLOGICAL PREPARATIONS FOR SWINES FOR THE TREATMENT OF AGALAXIA, CASTRATION; COLIBACILLOSIS, AUJESZKY'S DISEASE, GLASSER'S DISEASE, ENTERITTIS, ENTEROTOXEMIA, INFLUENZA, ERISIPELAS, PARVOVIROSIS, PLEUROPNEUMONIA, PRRS - PORCINE REPROCTIVE AND RESPIRATORY SYNDROME, RHINITIS, SEPTICEMIA; INJECTABLE PHARMACOLOGICAL PREPARATIONS FOR SWINES FOR THE TREATMENT OF ABORTION, ANAPHRODISIA, ANAEMIA, ARTHRITIS, DEHYDRATION, DIARRHOEA, DYSENTERY, ENTERITIS, STERILITY, HYPOCALCAEMIA, PARTURITION INDUCTION, RESPIRATORY INFECTIONS, INTOXICATIONS, MASTITIS/METRITIS, PNEUMONIA, SALMONELLOSIS, SPETICAEMIA, COUGH; ORLA VETERINARY PHARMACEUTICAL PREPARATIONS FOR SWINES FOR THE TREATMENT OF ANOREXIA, VITAMIN DEFICIENCIES, STRESS, RACHITISM; BIOLOGICAL PREPARATIONS FOR SHEEP FOR THE TREATMENT OF ABORTION, AGALAXIA, BEDSONIASIS,K ANTHRAX, CHLAMYDIOSIS, COLIBACILLOSIS, COLIBACILLOSIS, DYSENTERY, ENTEROTOXAEMIA, PASTEURELLOSIS, SEPTICAEMIA, TETANUS; INJECTABLE PHARMACOLOGICAL PREPARATIONS FOR SHEEP FOR THE TREATMENT OF CUTANEOUS ABSCESSES, ANAPHRODISIA, ARTHRITIS, BRONCHOPNEUMONIA, COLIBACILLOSIS, DECALCIFICATION, DEHYDRATION, DIARRHOEA, ENTERITIS, STERILITY, HEAT INDUCTION, MASTITIS/METRITIS, PNEUMONIA; PASTEURELLOSIS, FOOTROT, OESTRUS SYNCHRONIZATION, COUGH; ORAL VETERINARY PHARMACEUTICAL PREPARATIONS FOR SHEEP FOR THE TREATMENT OF ATONY, COCCIDIOSIS, DISINFECTION, DIARHOEA, DISTOMATOSIS, INDIGESTIONS, METEORISM, PULMONARY NEMATODIASIS, TAENIASIS; ORAL AND INJECTABLE VITAMINS FOR SHEEP FOR THE TREATMENT OF VITAMIN DEFICIENCIES AND GROWTH STIMULANT; BIOLOGICAL PREPARATIONS FOR CATTLE FOR THE TREATMENT OF AGALAXIA, BEDSONIASIS, BVD/BRS, ANTHRAX, CHLAMYDIASIS, ENTEROXAEMIA, IBR - INFECTIOUS BOVINE RHINOTRACHEITIS, PNEUMOENTERITIS, PARAINFLUENZA-3, RHINOTRACHEITIS, TETANUS; INJECTABLE PHARMACOLOGICAL PREPARATIONS FOR CATTLE FOR THE TREATMENT OF HEPATIC ABSCESSES, FOOT INFECTIONS, ANAEMIA, ARTHRITIS, BRONCHOPNEUMONIA, COLIBACILLOSIS, DIARRHOEA, ENTERITIS, STERILITY, HEAT INDUCTION/OESTRUS INDUCTION, INTOXICATIONS, MASTITIS/METRITIS, PNEUMONIA, PASTEURELLOSIS, SALMONELLOSIS, COUGH; ORAL PHARMACOLOGICAL PREPARATIONS FOR CATTLE FOR THE TREATMENT OF DIARRHOEA, DISROMATIONIS INDIGESTIONS, NEMATODIASIS, TAENIASIS, ORAL AND INJECTABLE VITAMINS FOR CATTLE FOR THE TREATMENT OF ANOREXIA, VITAMIN DEFICIENCIES, MYOPATHIES - WHITE MUSCLE DISEASE, STRESS; PHARMACEUTICAL PREPARATIONS FOR DOGS AND CATS FOR THE TREATMENT OF FOOT INFECTIONS, ALLERGY, VITAMIN DEFICIENCIES DIARRHOEA, OSTEOPOROSIS, RACHITISM, VETERINARY AND PHARMACEUTICAL PREPARATIONS FOR DOGS AND CATS FOR THE TREATMENT OF DERMATITIS AND SKIN REGENERATION; NUTRITIONAL ADDITIVES FOR LIVESTOCK FEED; VETERINARY DISINFECTANTS FOR POULTRY, BIRDS, RABBIT, PIG, SWINE, SHEEP, CALVE, COW AND EWEACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 23, 2020NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Jul 23, 2020RNL2REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jul 23, 202089AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jul 21, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 19, 2020E89RTEAS SECTION 8 & 9 RECEIVED—
May 21, 2010RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
May 21, 201089AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Apr 26, 201089AFREGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED—
Apr 26, 2010MAILPAPER RECEIVED—
Dec 10, 2008MDSCNOTICE OF DESIGN SEARCH CODE MAILED—
Oct 6, 20058.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Sep 6, 20058.AFREGISTERED - SEC. 8 (6-YR) FILED—
Sep 6, 2005MAILPAPER RECEIVED—
Jun 27, 2000R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 4, 2000PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 3, 2000NPUBNOTICE OF PUBLICATION—
Dec 3, 1999CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 15, 1999CNEAEXAMINER'S AMENDMENT MAILED—
Oct 13, 1999DOCKASSIGNED TO EXAMINER—
Jul 15, 19991.BDSec. 1(B) CLAIM DELETED—
Jul 12, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 11, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 30, 1998DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance